Latest News

FSD Pharma Announces US$20M At-The-Market Offering

TORONTO–(BUSINESS WIRE)– #FSDDF–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has entered into an Equity Distribution Agreement dated July 10, 2020 (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”). Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company (the “Class B Sh

Source link

Related posts

Toothpaste And Mouthwash Use May Cause Antibiotic Resistance


GMC plans to speed up FTP decision-making


Medical News Today: Ativan vs. Xanax: What are the differences?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World